Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·What happens when researchers remove cells that stop dividing in diseased lung arteries
Review or Meta-AnalysisA review compares opposing animal results in pulmonary hypertension, showing why timing remains a hypothesis and how changing cell signals differs from removing cells.
-
Evidence date ·How immune cells can both age tissues and clear cells that stop dividing
Review or Meta-AnalysisA 2025 review connects immune aging with senescent-cell buildup and compares human tissue findings with animal results from drugs and engineered T cells.
-
Evidence date ·How drug research is targeting different routes in immune aging after COVID
Review or Meta-AnalysisA December 2024 review compares drug targets in acute COVID, brain-inflammation models and other diseases, while patient benefit remains uncertain.
-
Evidence date ·Cell removal produces conflicting results in animal models of lung artery disease
Review or Meta-AnalysisA 2024 review compares animal studies in which removing senescent cells helped or harmed lung arteries. Benefits in people remain unproven.
-
Evidence date ·Could changing how immune and lung cells use energy control chronic inflammation?
Review or Meta-AnalysisAn EAACI position paper connects cellular energy use with persistent lung inflammation, separating patient observations from experimental treatment evidence.
-
Evidence date ·Can aging treatments extend healthy life without harming repair?
Review or Meta-AnalysisClearing senescent cells benefited aged mice but impaired repair in young mouse lungs. These findings leave human benefits and safe targeting unresolved.
-
Evidence date ·Aging immunity needs repair at several levels
Review or Meta-AnalysisA July 2023 review explains why aging can leave immunity inflamed yet fragile, and contrasts cell repair, senescent-cell removal and targeted delivery.
-
Evidence date ·What dasatinib plus quercetin did beyond eating less in monkeys
Peer-Reviewed PaperIn 16 macaques, dasatinib plus quercetin altered selected biomarkers and may have added to calorie restriction’s effect on HbA1c, a blood-sugar measure.
-
Evidence date ·How aging changes the timing and coordination of the COVID-19 immune response
Review or Meta-AnalysisA December 2021 review links delayed antiviral signals, narrower immune recognition and comorbidities to COVID-19 vulnerability; treatment benefits remain unproven.
-
Evidence date ·How cell maintenance can shape the health of whole organs
Review or Meta-AnalysisA 2022 synthesis links protein maintenance, autophagy and senescent-cell signals to organ function, while clinical outcomes remain disease-specific.